drugset
drugset / Trial / NCT02086591

A Phase II Study of Doxycycline in Relapsed NHL

NCT02086591 ↗

Phase 2 Terminated 7 enrolled University of Rochester
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether doxycycline is effective in the treatment of relapsed Non Hodgkin Lymphomas (NHL).

Timeline

Start
2014-03
Primary completion
2015-07
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 200 mg Oral

Indications

T-cell non-Hodgkin lymphoma Waldenstrom macroglobulinemia chronic lymphocytic leukemia/small lymphocytic lymphoma diffuse large B-cell lymphoma follicular lymphoma mantle cell lymphoma marginal zone lymphoma